Skip to content

Microbicides 2004 marks new wave of HIV prevention trials

ARV-based HIV microbicides advanced by ground-breaking partnership

Rectal HIV microbicides still a distant prospect

Resistant HIV strains persist after at least five years on suppressive HAART

Fosamprenavir recommended for approval as Telzir in Europe

US treatment guidelines updated

Atazanavir interactions with tenofovir and Viagra included on new US labelling

Kidney stones and other calculus build-up seen in 4% of those on Kaletra-based HAART

HAART takes more than a year to suppress Kaposi’s sarcoma virus